Please login to the form below
Scotland
This page shows the latest Scotland news and features for those working in and with pharma, biotech and healthcare.
Vertex scores CF deal with Scotland, but access debate continues
The agreement has been reached after extensive discussions between the Scottish Government and Vertex Pharmaceuticals and means the medicines will now be made available to patients on the NHS in Scotland, ... Tensions are likely to rise in England
Latest news
-
Roche’s Hemlibra scores broader NHS funding
Roche says reimbursement discussions in Scotland, Wales and Northern Ireland are also currently progressing.
-
Vertex faces rejection of its CF medicines in Scotland
Another rejection over cost-effectiveness. The Scottish Medicines Consortium (SMC) has not recommended Vertex’s cystic fibrosis drugs Orkambi (lumacaftor/ivacaftor) and Symkevi (tezacaftor/ivacaftor) for routine NHS use in Scotland. . ... CF is an
-
Europe urged to adapt faster to gene therapy challenges
Existing models include conditional reimbursement, such as England’s Cancer Drugs Fund and Scotland’s fund for ultra-orphan drugs.
-
Charity launches real-world medical cannabis study
Just this week, a mother in Scotland was visited by police after admitting smuggling cannabis oil into the UK for her son, who has a rare form of epilepsy.
-
NHS England wants money-back guarantee on Orkambi
It also says it has offered an interim access deal to provide immediate access to eligible patients to Orkambi, on terms similar to those accepted in Scotland, where a deal has
More from news
Approximately 6 fully matching, plus 221 partially matching documents found.
Latest Intelligence
-
The UK’s new medicines pricing deal – opportunities and risks for pharma
Different from the 2014 PPRS is the requirement for companies to offer the same deal – whether agreed in England, Scotland, Wales or Northern Ireland – across all nations.
-
The Orkambi row explained
May 2016: Orkambi and Kalydeco rejected in Scotland. June 2016: NICE gives final rejection of Orkambi in England – the Cystic Fibrosis Trust suggests a solution using the UK CF Registry to
-
The Orkambi blame game
Leiden added: “It could be the same price as Scotland. That’s the quickest way.”. ... Deciphering the feasibility of this hope was difficult for the MPs, as Scotland’s deal with Vertex remains confidential.
-
#OrkambiNow?
A market access deal with Scotland’s government has provided new impetus to the talks in England, with the hope that both sides can climb down and reach agreement soon.
-
Brain power: fresh approaches to Alzheimer’s drug discovery
others) and universities across six European countries, from Edinburgh in Scotland to Zaragoza in Spain.
More from intelligence
Approximately 0 fully matching, plus 17 partially matching documents found.
Latest appointments
-
ClinTec International adds to senior leadership team
Prior to working for inVentiv Health, Dr Reekie served as chief operating officer at PharmaNet prior to its acquisition by inVentiv, commercial director at Stratified Medicine Scotland-Innovation Centre and head
-
ABPI Scotland appoints Sandra Auld as director
She will spearhead the ABPI Scotland team, working closely with the Scottish Government and NHS Scotland. . ... Auld added: “I am absolutely delighted to become the Director of ABPI Scotland.
-
Former RBS head takes the reins as GSK chair
Sir Philip, formerly the chair of the Royal Bank of Scotland, replaces Sir Christopher Gent, who announced he would step down from the position last year.
-
EFPIA looks to ABPI for comms director
Powrie-Smith is currently director of the ABPI's operations in Scotland and also heads the trade body's Trust and Reputation network.
-
Sir Philip Hampton set to be new GSK chair
RBS chairman to replace Sir Christopher Gent. GlaxoSmithKline (GSK) is set to name the Royal Bank of Scotland's (RBS) Sir Philip Hampton as the company's new chairman, according to
More from appointments
Approximately 2 fully matching, plus 4 partially matching documents found.
Latest from PMHub
-
What are you doing, Dave?
NHS 24 in Scotland now has a symptom checker app. Babylon, the healthcare company that offers 'virtual GP' services, has created an NHS 111 app including a paediatric symptom checker for
-
Givers and Takers
limits. And let’s not even talk about the proud descendant of an immigrant family from Scotland who wants to stop other well-intentioned immigrants from entering the USA – let’s
-
World AIDS Day 2018: Fighting the stigma surrounding HIV
This is currently being trialled throughout England and is already widely available in Scotland.
-
Porterhouse Medical strengthens the team with three new members.
Alex is relocating from Scotland, where he completed a research MSc in molecular and clinical medicine focused on castrate-resistant prostate cancer at the University of Edinburgh.
-
Wearables and Healthcare
treat. A shining example of data hard at work in healthcare comes from north of the border in Scotland.
More from PMHub
Approximately 0 fully matching, plus 20 partially matching documents found.
Featured jobs
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
-
Events Executive
-
DOE
-
Senior Medical Writer
-
Competitive salary plus benefits
- Client Services Director- Flexible Working
-
Negotiable
-
Account Director – UK Office
-
Excellent salary and benefits
- Account Manager – Healthcare advertising
-
Salary TBC
Subscribe to our email news alerts
- Novartis eyes potential new indication for Cosentyx
- J&J's Tremfya filed for approval in US for psoriatic arthritis
- AbbVie/Allergan's merger faces public opposition
- Envision Pharma Group relocates to support expansion
- Biogen loses another pipeline drug to toxicity concerns
- AZ, Merck’s Lynparza scores market-expanding clinical success
- Report: Customer experience, shaping digital healthcare
- The benefits of uniting in a divergent environment
- Encouraging signs in biomarker R&D
- J&J puts pressure on rivals with new Erleada okay in prostate cancer
- Pharma exhibition stand design with added value
- Bluebird Bio reveals further encouraging data for CALD gene therapy
PMHub
Blue Latitude Health
Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...
Latest intelligence
- Report: Customer experience, shaping digital healthcare
- In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
- Encouraging signs in biomarker R&D
- The cancer immunotherapy firms ramping-up biomarker R&D...
- Programmatic methodology and why you should be using it
- What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...
Quick links
Infographics
